Reversal of brain essential fatty-acid deficiency in the rat by dietary linoleate, linolenate and arachidonate.
D015126:8,11,14-Eicosatrienoic Acid / Q000378:metabolism; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000627:therapeutic use*; D001921:Brain / Q000033:anatomy & histology / Q000378:metabolism*; D002554:Cerebrosides / Q000378:metabolism; D004041:Dietary Fats / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000172:deficiency*; D005260:Female; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000627:therapeutic use*; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013109:Sphingomyelins / Q000378:metabolism
D001095:Arachidonic Acids; D002554:Cerebrosides; D004041:Dietary Fats; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D013109:Sphingomyelins; D016718:Arachidonic Acid; D019787:Linoleic Acid; D015126:8,11,14-Eicosatrienoic Acid